Anticoagulants or antiplatelet therapy for non‐rheumatic atrial fibrillation and flutter

JB Segal, R McNamara, MM Miller… - Cochrane Database …, 1996 - cochranelibrary.com
Background Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …
被引用次数：143 相关文章

WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

JB Segal, RL McNamara, MR Miller… - The Cochrane …, 2007 - europepmc.org
Background Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …

[引用][C] Anticoagulants or antiplatelet therapy for non‐rheumatic atrial fibrillation and flutter

JB Segal, R McNamara, M Miller… - Cochrane Database …, 2006 - cochranelibrary.com
Date: May 20th 2006 (Issue 3 2006) This review is out of date and had been withdrawn. This
topic is now the subject of a published systematic review" Antiplatelet therapy for preventing …

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

JB Segal, RL McNamara, MR Miller… - Cochrane database …, 2001 - pure.johnshopkins.edu
BACKGROUND: Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …

WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter

JB Segal, RL McNamara, MR Miller… - The Cochrane …, 2007 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …

Anticoagulants or antiplatelet therapy for non‐rheumatic atrial fibrillation and flutter

JB Segal, R McNamara, M Miller, N Powe… - The Cochrane …, 2006 - ncbi.nlm.nih.gov
Date: May 20th 2006 (Issue 3 2006) This review is out of date and had been withdrawn. This
topic is now the subject of a published systematic review" Antiplatelet therapy for preventing …

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter

JB Segal, RL McNamara, MR Miller… - The Cochrane …, 2001 - pubmed.ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …

Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

JB Segal, RL McNamara, MR Miller… - The Cochrane …, 2001 - europepmc.org
BACKGROUND: Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …

WITHDRAWN: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

JB Segal, RL McNamara, MR Miller… - Cochrane database …, 2007 - pure.johnshopkins.edu
BACKGROUND: Atrial fibrillation (AF) carries a high risk of stroke and other thromboembolic
events. Appropriate use of drugs to prevent thromboembolism in patients with AF involves …